Anlotinib plus Pemetrexed
ALTER-L025
Phase 2 small_molecule active
Quick answer
Anlotinib plus Pemetrexed for Non-squamous Cell Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Henan Provincial People's Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Henan Provincial People's Hospital
- Indication
- Non-squamous Cell Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active